Black Rock Inc. Myriad Genetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 15,150,806 shares of MYGN stock, worth $253 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,150,806
Previous 14,879,319
1.82%
Holding current value
$253 Million
Previous $317 Million
16.82%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MYGN
# of Institutions
254Shares Held
90.9MCall Options Held
100KPut Options Held
34K-
Vanguard Group Inc Valley Forge, PA10.3MShares$172 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$112 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$86.4 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$78.5 Million0.01% of portfolio
-
Earnest Partners LLC Atlanta, GA3.96MShares$66 Million0.49% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.35B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...